Stryker recommends more vigilant monitoring of patients with recalled hip implants

By

Stryker recommends more vigilant monitoring of patients with recalled hip implants (MassDevice)
Stryker's Australian division recommends regular blood tests and soft tissue imaging for all patients implanted with the now-recalled ABG II Modular metal-on-metal implants.
Stryker's  Australian arm provided national health regulators with updated recommendations for monitoring patients who received the company's now-recalled ABG II Modular hip systems.
Australia's Therapeutic Goods Admin. issued the new guidelines for patient follow-up, advising regular blood testing and soft tissue cross-sectiona...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.